Skip banner Home   Sources   How Do I?   Site Map   What's New   Help  
Search Terms: medicare prescription drug
  FOCUS™    
Edit Search
Document ListExpanded ListKWICFULL format currently displayed   Previous Document Document 178 of 532. Next Document

Copyright 2002 The New York Times Company  
The New York Times

July 29, 2002, Monday, Late Edition - Final

SECTION: Section A; Page 18; Column 1; Editorial Desk 

LENGTH: 490 words

HEADLINE: Searching for a Drug Compromise

BODY:
Ever since rival Democratic and Republican bills to provide Medicare prescription drug coverage for the elderly went down to defeat in the Senate last week, anxious senators have been scrambling to find a compromise that might attract the 60 votes needed to assure passage. The Democrats feel a particular urgency to pass a bill given that the Republican-controlled House has already done so. But several Senate Republicans in tough re-election campaigns also want to come up with something to parade before the elderly in the fall campaigns. It is critical that enough bipartisan support be found to push through a meaningful drug benefit this week before the Senate begins its August recess.

At the close of last week, two major alternatives had emerged as possible compromises. Each would cost substantially less than the Democratic bill that went down to defeat last week because its eight-year $594-billion price tag proved too much for the Senate to swallow. Even so, the two alternatives under discussion would cost at the very least $400 billion over the same period.

One alternative, which Senators Bob Graham, Democrat of Florida, and Gordon Smith, Republican of Oregon, plan to introduce this week, would provide virtually complete coverage of all drug purchases for low-income Americans except for a nominal co-payment. For everyone else, there would be discount cards projected to shave 20 percent or more off the price of prescription drugs and a limit of $4,000 in out-of-pocket spending, after which the federal government would pay everything but a small co-payment per prescription. The great virtue of this approach is that it focuses help where it is most needed -- on low-income individuals and those with high drug bills.

The other leading alternative would build on the Republican-backed "tripartisan" bill that also went down to defeat last week, but would sweeten it to attract more Democratic support. In one preliminary version, low-income Americans would get substantially complete coverage, while everyone else would share the costs 50-50 with the federal government until reaching a $6,000 limit, after which the government would pick up 90 percent of the cost. The plan would rely on private insurers to keep costs down through competition. Senators who are worried about the reaction of middle-class elderly voters -- a critical constituency that turns out heavily in off-year elections -- will probably find this approach appealing.

We prefer a bill with a lower limit on catastrophic coverage. While it's impossible to really compare legislative proposals that have yet to be submitted in writing or subjected to the same objective analysis of their cost, the guidelines should be clear: It is more important to protect people completely with thousands of dollars in prescription expenses than to dole out bits of aid to those whose bills run in the hundreds.  

http://www.nytimes.com

LOAD-DATE: July 29, 2002




Previous Document Document 178 of 532. Next Document
Terms & Conditions   Privacy   Copyright © 2003 LexisNexis, a division of Reed Elsevier Inc. All Rights Reserved.